Description
Idarub Iv Ingredients
The primary component of “Idarub Iv Liyofilize Powder Iceren Vial 10 Mg” is Idarubicin Hcl 10 Mg. Unfortunately, detailed information about additional ingredients remains unavailable. To gain a comprehensive understanding of this medication, it is advisable to consult a healthcare professional. Please note that this data may be incomplete or outdated, emphasizing the importance of consulting a healthcare expert for precise information.
Idarubicin Hcl and its Mechanism
Idarubicin Hcl, the active ingredient within “Idarub Iv Liyofilize Powder Iceren Vial 10 Mg,” is a hydrochloride salt form of Idarubicin. This compound belongs to the class of anthracycline antibiotics and serves as a DNA topoisomerase II (topo II) inhibitor.
Idarubicin Hcl’s efficacy has been demonstrated against MCF-7 cells, with an IC50 of 3.3 ng/mL in a cell-free assay. In essence, an Idarubicin Hcl concentration of 3.3 ng/mL is required to inhibit topo II activity by 50%.
This medication operates by integrating itself into DNA, thereby impeding DNA unwinding through interference with the enzyme topoisomerase II. It’s worth noting that Idarubicin is an analog of daunorubicin, with its increased fat solubility and cellular uptake attributed to the absence of a methoxy group.
Clinical Application of Idarubicin
Idarubicin is primarily employed in conjunction with other medications for the treatment of acute myelogenous leukemia (AML), a form of cancer affecting white blood cells. Its mechanism of action revolves around slowing or halting the growth of cancerous cells within the body.
Dosage and Packaging
The dosage format of “Idarub Iv Liyofilize Powder Iceren Vial 10 Mg” is presented in vial form. Each package comprises a single vial, with a potency of 10 Mg.
Availability and Additional Information
It’s important to note that this medication may not be readily accessible and could necessitate special ordering. In cases of urgent requirement, you may explore options on the Urgent Quotation page.
Regrettably, more specific details regarding “Idarub Iv Liyofilize Powder Iceren Vial 10 Mg” remain elusive in both Turkish and English sources. For comprehensive insights into this medication, consulting a healthcare professional is strongly recommended.
Usage and Conclusion
“Idarub Iv Liyofilize Powder Iceren Vial 10 Mg,” manufactured by Kocak in Turkey, boasts Idarubicin Hcl 10 Mg as its active ingredient. While precise information regarding its usage is currently unavailable, consulting with a healthcare professional is the most reliable avenue for acquiring detailed insights.
Conclusion
In conclusion, Idarubicin Hcl 10 Mg presents a promising avenue in the battle against acute myelogenous leukemia. Its unique mechanism of action underscores its significance in the realm of cancer treatment. However, for tailored guidance and the most accurate and up-to-date information, a healthcare professional should be your primary source of reference.
Disclaimer: This article serves as an informative resource and should not be interpreted as medical advice. For personalized guidance and the latest information, consult with a qualified healthcare provider.
General Information |
---|
– Medication: Idarub Iv Liyofilize Powder Iceren Vial 10 Mg |
– Manufacturer: Kocak, Turkey |
– Generic Name: Idarubicin Hcl 10 Mg |
Reviews
There are no reviews yet.